{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:30:20Z","timestamp":1793313020859,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Raised serum resistin is adjudged to increase the likelihood of insulin resistance (IR) and type 2 diabetes mellitus (T2DM) through multiple biochemical pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The current study assessed the likelihood of IR and T2DM among Nigerians based on serum resistin status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This case-controlled study was conducted at a tertiary hospital in southern Nigeria, among 100 T2DM patients matched with age\/gender controls. Sociodemographic, anthropometric, clinical, and laboratory data, including serum resistin status, were collected using standard protocols. T2DM diagnosis was made using recommended guidelines. Statistical analyses were conducted using descriptive statistics, logistic regression models, and area under the curve (AUC) of the receiver-operating characteristic curve at a 95% confidence level (CI) and an alpha value of &lt;0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      T2DM patients had higher mean values of body mass index (BMI), fasting plasma glucose (FPG), fasting serum insulin (FIN), homoeostatic model assessment of IR values (HOMA-IR) and serum resistin compared to controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Compared to the lowest quartile of serum resistin among T2DM patients, the likelihood of attaining IR status and T2DM risk increased with increasing quartiles of serum resistin, independent of matching factors (age\/gender), occupation, BMI, FPG, FIN and HOMA-IR (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>trend<\/jats:sub>\n                      &lt; 0.001). Increasing serum resistin had good predictive value on the likelihood of attaining IR status (AUC: 0.79; 95% CI: 0.72\u20130.85;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and T2DM risk (AUC: 0.89; 95% CI: 0.83\u20130.93;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current findings indicate a likelihood of IR and T2DM in association with increasing serum resistin, corroborating the role of resistin in T2DM through IR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/npmj.npmj_458_25","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:00:37Z","timestamp":1772434837000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the Likelihood of Insulin Resistance and Type 2 Diabetes Mellitus Based on Serum Resistin Status among Nigerians"],"prefix":"10.4103","volume":"33","author":[{"given":"Johnbosco Chidozie","family":"Okafor","sequence":"first","affiliation":[{"name":"Department of Chemical Pathology, University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehimen P.","family":"Odum","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.","family":"Okpara","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Amadi","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"1192629","DOI":"10.3389\/fendo.2023.1192629","article-title":"The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019","volume":"14","author":"Ye","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40842-024-00209-1","article-title":"A systematic review and meta-analysis of the prevalence and risk factors of type 2 diabetes mellitus in Nigeria","volume":"10","author":"Olamoyegun","year":"2024","journal-title":"Clin Diabetes Endocrinol"},{"key":"R3-20260420","first-page":"17","article-title":"Gender and age-specific prevalence and associated risk factors of type 2 diabetes mellitus in Uyo metropolis, South-Eastern Nigeria","volume":"41","author":"Ekpenyong","year":"2012","journal-title":"Diabetologia Croat"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"142","DOI":"10.11648\/j.ijde.20210604.14","article-title":"The incident pattern and trend of type 2 diabetes among adults in Akwa Ibom State, South-South Nigeria","volume":"4","author":"Amadi","year":"2021","journal-title":"Int J Diabetes Endocrinol"},{"key":"R5-20260420","first-page":"176","article-title":"Prevalence of type 2 diabetes mellitus in adults in uyo local government area, Akwa Ibom State, Nigeria","volume":"8","author":"Merenini","year":"2025","journal-title":"Asian J Med Princ Clin Pract"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: New pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/dc08-1625","article-title":"Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts","volume":"32","author":"Chen","year":"2009","journal-title":"Diabetes Care"},{"key":"R8-20260420","first-page":"552","article-title":"Relationship of serum resistin with insulin resistance and Obesity","volume":"27","author":"Zaidi","year":"2015","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diabet.2010.05.003","article-title":"Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients","volume":"36","author":"Gharibeh","year":"2010","journal-title":"Diabetes Metab"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"100059","DOI":"10.1016\/j.endmts.2020.100059","article-title":"Circulating resistin levels in relation with insulin resistance, inflammatory and endothelial dysfunction markers in patients with type 2 diabetes and impaired fasting glucose","volume":"1","author":"Siddiqui","year":"2020","journal-title":"Endocr Metab Sci"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2265.2007.03154.x","article-title":"Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes","volume":"69","author":"Osawa","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 2","key":"R12-20260420","doi-asserted-by":"crossref","first-page":"S1053","DOI":"10.1016\/j.dsx.2017.07.040","article-title":"Serum resistin levels inversely associated with cardiovascular risk indices in type 2 diabetics from central Mexico","volume":"11","author":"Solis-Cano","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s13300-018-0441-1","article-title":"Prevalence and risk factors for diabetes mellitus in Nigeria: A systematic review and meta-analysis","volume":"9","author":"Uloko","year":"2018","journal-title":"Diabetes Ther"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.56397\/JIMR\/2023.04.06","article-title":"Body Mass Index (BMI) is a popular anthropometric tool to measure obesity among adults","volume":"2","author":"Mohajan","year":"2023","journal-title":"J Innov Med Res"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"e0282433","DOI":"10.1371\/journal.pone.0282433","article-title":"The metabolic profile of waist to hip ratio-a multi-cohort study","volume":"18","author":"Lind","year":"2023","journal-title":"PLoS One"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/jpm13010060","article-title":"Predictability of HOMA-IR for gestational diabetes mellitus in early pregnancy based on different first trimester BMI values","volume":"13","author":"Duo","year":"2022","journal-title":"J Pers Med"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"101934","DOI":"10.1016\/j.eclinm.2023.101934","article-title":"Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: A prospective cohort study","volume":"58","author":"Tsai","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-149-5-200809020-00005","article-title":"Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women","volume":"149","author":"Heidemann","year":"2008","journal-title":"Ann Intern Med"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jscs.2012.07.003","article-title":"Correlation of serum resistin level with insulin resistance and severity of retinopathy in type 2 diabetes mellitus","volume":"20","author":"Azab","year":"2016","journal-title":"J Saudi Chem Soc"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12291-014-0459-8","article-title":"Association of resistin with insulin resistance and factors of metabolic syndrome in North Indians","volume":"30","author":"Singh","year":"2015","journal-title":"Indian J Clin Biochem"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fphys.2019.01399","article-title":"Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: A systematic review and meta-analysis","volume":"10","author":"Su","year":"2019","journal-title":"Front Physiol"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/eje.1.02311","article-title":"Genetic and environmental determinants of circulating resistin level in a community-based sample","volume":"156","author":"Pantsulaia","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R25-20260420","first-page":"65","article-title":"Resistin: It\u2019s role in insulin resistance and mechanism of action","volume":"68","author":"Ren","year":"2016","journal-title":"Sheng Li Xue Bao"},{"issue":"9","key":"R26-20260420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s43088-020-00078-4","article-title":"Molecular mechanisms and the vital roles of resistin, TLR 4, and NF-\u03baB in treating type 2 diabetic complications","volume":"17","author":"Gudise","year":"2020","journal-title":"Beni-Suef Univ J Basic Appl Sci"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_458_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:09Z","timestamp":1787771829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_458_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_458_25","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2025-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}